Odd Erik Johansen

Affiliations

Boehringer Ingelheim Norway KS, Asker, Norway.

ORCID: 0000-0003-2470-0530

Publications (1)

Cardiovascular and kidney outcomes of linagliptin treatment in older people with type 2 diabetes and established cardiovascular disease and/or kidney disease: A prespecified subgroup analysis of the randomized, placebo-controlled CARMELINA® trial.

Diabetes, obesity & metabolism

Avec: Mark E Cooper , Julio Rosenstock , Takashi Kadowaki , Yutaka Seino , Christoph Wanner , Sven Schnaidt , Douglas Clark , Auteur inconnu

Réseau de co-auteurs

Mark E Cooper 1 collaboration

Julio Rosenstock 1 collaboration

Takashi Kadowaki 1 collaboration

Yutaka Seino 1 collaboration

Christoph Wanner 1 collaboration

Sven Schnaidt 1 collaboration

Douglas Clark 1 collaboration

None None 1 collaboration